Citation Impact
Citing Papers
Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer
2006
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Hallmarks of Cancer: The Next Generation
2011 Standout
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
2004 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Triple-Negative Breast Cancer
2010 Standout
Stromal biology of pancreatic cancer
2007
The DNA-damage response in human biology and disease
2009 StandoutNature
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Tumour escape from immune surveillance through dendritic cell inactivation
2002
Inflammation and cancer
2002 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Is there an inhibitory effect of COX-2 inhibitors on bone healing?
2004
The role of COX-2 inhibition in breast cancer treatment and prevention
2004
Metronomic scheduling: the future of chemotherapy?
2001
Cancer Metastasis: Building a Framework
2006 Standout
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
COX-2 inhibition and colorectal cancer
2004
Dual-delivery of VEGF and PDGF by double-layered electrospun membranes for blood vessel regeneration
2013
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Bone cancer pain: Causes, consequences, and therapeutic opportunities
2013
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
2011 StandoutNature
COX-2 inhibition and prevention of cancer
2001
Evolving functions of endothelial cells in inflammation
2007
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Prostaglandin E2 Induces Hypoxia-inducible Factor-1α Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line
2002
Cyclooxygenase 2 Expression in Pancreatic Adenocarcinoma and Pancreatic Intraepithelial Neoplasia
2002
The Citrus Flavonoid, Nobiletin, Inhibits Peritoneal Dissemination of Human Gastric Carcinoma in SCID Mice
2001
Angiogenesis in life, disease and medicine
2005 StandoutNature
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
2009 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis
2000
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Molecular genetics of pancreatic intraepithelial neoplasia
2007
GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model
2008
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Mechanisms of smoking-related lung and pancreatic adenocarcinoma development
2002
EMT: 2016
2016 Standout
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Inflammation and the development of pancreatic cancer
2002
ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
2005
Therapeutic Potential of Selective Cyclooxygenase-2 Inhibitors in the Management of Tumor Angiogenesis
2003
An aging Interventions Testing Program: study design and interim report
2007
Origin and physiological roles of inflammation
2008 StandoutNature
Inflammation and Cancer: Is the Link as Simple as We Think?
2005
Pancreatic Cancer
2010 Standout
Pancreatic cancer biology and genetics
2002
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
2007
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches
2001
Angiogenesis as a therapeutic target
2005 StandoutNature
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
2001
Genetic Progression in the Pancreatic Ducts
2000
The hairless mouse in skin research
2008
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
2002
Progression model for pancreatic cancer.
2000
Gender Differences in UVB-Induced Skin Carcinogenesis, Inflammation, and DNA Damage
2007
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Basal-Like Breast Cancer: A Critical Review
2008
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Protein Conformational Changes in Breast Cancer Sera Using Infrared Spectroscopic Analysis
2020
Induction of a CD4+ T Regulatory Type 1 Response by Cyclooxygenase-2-Overexpressing Glioma
2004
Cytokine Storm
2020 Standout
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers
2000
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?
2003
Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy
2004
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Angiogenesis in Endocrine Tumors
2003
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
2001
Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?
2005
Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis
2013
Myocardial ischemia and infarction: growth of ideas
2001
Works of Alane Koki being referenced
Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis
2005
Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
2002
Celecoxib: A Specific COX-2 Inhibitor with Anticancer Properties
2002
Role of Cyclooxygenases in Angiogenesis
2000
Identification and validation of an ERBB2 gene expression signature in breast cancers
2004
Inhibition of cutaneous ultraviolet light B–mediated inflammation and tumor formation with topical celecoxib treatment
2003
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
2000
EXPRESSION OF CYCLOOXYGENASE (COX) -1 AND COX-2 IN HUMAN INVASIVE TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER
1999
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
1999
Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal Antiinflammatory Drug-Related Nephrotoxicity
1998
COX‐2 Inhibitors: A New Class of Antiangiogenic Agents
1999
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
1999
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
2000
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
2000
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
2002
Targeting Cyclooxygenase-2 Reduces Overt Toxicity toward Low-Dose Vinblastine and Extends Survival of Juvenile Mice with Friend Disease
2005
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder.
1999
Cyclooxygenase-2 is overexpressed in human cervical cancer.
2001